nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazamide—Reaction gastrointestinal—Azathioprine—systemic scleroderma	0.0392	0.0392	CcSEcCtD
Tolazamide—Heartburn—Pentoxifylline—systemic scleroderma	0.0288	0.0288	CcSEcCtD
Tolazamide—Aplastic anaemia—Pentoxifylline—systemic scleroderma	0.0186	0.0186	CcSEcCtD
Tolazamide—Digestion impaired—Leflunomide—systemic scleroderma	0.0185	0.0185	CcSEcCtD
Tolazamide—Inappropriate antidiuretic hormone secretion—Lisinopril—systemic scleroderma	0.0183	0.0183	CcSEcCtD
Tolazamide—Jaundice cholestatic—Captopril—systemic scleroderma	0.0171	0.0171	CcSEcCtD
Tolazamide—Reaction gastrointestinal—Methotrexate—systemic scleroderma	0.0158	0.0158	CcSEcCtD
Tolazamide—Heartburn—Lisinopril—systemic scleroderma	0.0154	0.0154	CcSEcCtD
Tolazamide—Jaundice cholestatic—Azathioprine—systemic scleroderma	0.0149	0.0149	CcSEcCtD
Tolazamide—Jaundice cholestatic—Mycophenolic acid—systemic scleroderma	0.0134	0.0134	CcSEcCtD
Tolazamide—Abdominal distension—Pentoxifylline—systemic scleroderma	0.0125	0.0125	CcSEcCtD
Tolazamide—Aplastic anaemia—Azathioprine—systemic scleroderma	0.0123	0.0123	CcSEcCtD
Tolazamide—Jaundice cholestatic—Lisinopril—systemic scleroderma	0.0121	0.0121	CcSEcCtD
Tolazamide—Haemolytic anaemia—Captopril—systemic scleroderma	0.0121	0.0121	CcSEcCtD
Tolazamide—Pancytopenia—Pentoxifylline—systemic scleroderma	0.0118	0.0118	CcSEcCtD
Tolazamide—Hyponatraemia—Captopril—systemic scleroderma	0.0109	0.0109	CcSEcCtD
Tolazamide—Jaundice cholestatic—Mycophenolate mofetil—systemic scleroderma	0.0106	0.0106	CcSEcCtD
Tolazamide—Pancytopenia—Captopril—systemic scleroderma	0.00894	0.00894	CcSEcCtD
Tolazamide—Hypoglycaemia—Mycophenolic acid—systemic scleroderma	0.00877	0.00877	CcSEcCtD
Tolazamide—Aplastic anaemia—Mycophenolate mofetil—systemic scleroderma	0.00874	0.00874	CcSEcCtD
Tolazamide—Erythema—Pentoxifylline—systemic scleroderma	0.00865	0.00865	CcSEcCtD
Tolazamide—Hyponatraemia—Mycophenolic acid—systemic scleroderma	0.00859	0.00859	CcSEcCtD
Tolazamide—Photosensitivity reaction—Captopril—systemic scleroderma	0.00859	0.00859	CcSEcCtD
Tolazamide—Eruption—Methotrexate—systemic scleroderma	0.00857	0.00857	CcSEcCtD
Tolazamide—Haemolytic anaemia—Lisinopril—systemic scleroderma	0.00854	0.00854	CcSEcCtD
Tolazamide—Ill-defined disorder—Pentoxifylline—systemic scleroderma	0.00803	0.00803	CcSEcCtD
Tolazamide—Hypoglycaemia—Lisinopril—systemic scleroderma	0.0079	0.0079	CcSEcCtD
Tolazamide—Agranulocytosis—Captopril—systemic scleroderma	0.00783	0.00783	CcSEcCtD
Tolazamide—Malaise—Pentoxifylline—systemic scleroderma	0.0078	0.0078	CcSEcCtD
Tolazamide—Pancytopenia—Azathioprine—systemic scleroderma	0.0078	0.0078	CcSEcCtD
Tolazamide—Leukopenia—Pentoxifylline—systemic scleroderma	0.00774	0.00774	CcSEcCtD
Tolazamide—Hyponatraemia—Lisinopril—systemic scleroderma	0.00774	0.00774	CcSEcCtD
Tolazamide—Haemolytic anaemia—Mycophenolate mofetil—systemic scleroderma	0.00748	0.00748	CcSEcCtD
Tolazamide—Abdominal distension—Mycophenolic acid—systemic scleroderma	0.00745	0.00745	CcSEcCtD
Tolazamide—Pancytopenia—Leflunomide—systemic scleroderma	0.00736	0.00736	CcSEcCtD
Tolazamide—Discomfort—Pentoxifylline—systemic scleroderma	0.00728	0.00728	CcSEcCtD
Tolazamide—Pancytopenia—Mycophenolic acid—systemic scleroderma	0.00703	0.00703	CcSEcCtD
Tolazamide—Hypoglycaemia—Mycophenolate mofetil—systemic scleroderma	0.00692	0.00692	CcSEcCtD
Tolazamide—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.00691	0.00691	CcSEcCtD
Tolazamide—Agranulocytosis—Azathioprine—systemic scleroderma	0.00683	0.00683	CcSEcCtD
Tolazamide—Hyponatraemia—Mycophenolate mofetil—systemic scleroderma	0.00678	0.00678	CcSEcCtD
Tolazamide—Agranulocytosis—Leflunomide—systemic scleroderma	0.00645	0.00645	CcSEcCtD
Tolazamide—Pancytopenia—Lisinopril—systemic scleroderma	0.00633	0.00633	CcSEcCtD
Tolazamide—Dyspepsia—Pentoxifylline—systemic scleroderma	0.00621	0.00621	CcSEcCtD
Tolazamide—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.00616	0.00616	CcSEcCtD
Tolazamide—Ill-defined disorder—Captopril—systemic scleroderma	0.00608	0.00608	CcSEcCtD
Tolazamide—Photosensitivity reaction—Lisinopril—systemic scleroderma	0.00608	0.00608	CcSEcCtD
Tolazamide—Malaise—Captopril—systemic scleroderma	0.00591	0.00591	CcSEcCtD
Tolazamide—Abdominal distension—Mycophenolate mofetil—systemic scleroderma	0.00588	0.00588	CcSEcCtD
Tolazamide—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00582	0.00582	CcSEcCtD
Tolazamide—Urticaria—Pentoxifylline—systemic scleroderma	0.00561	0.00561	CcSEcCtD
Tolazamide—Pancytopenia—Mycophenolate mofetil—systemic scleroderma	0.00554	0.00554	CcSEcCtD
Tolazamide—Agranulocytosis—Lisinopril—systemic scleroderma	0.00554	0.00554	CcSEcCtD
Tolazamide—Discomfort—Captopril—systemic scleroderma	0.00551	0.00551	CcSEcCtD
Tolazamide—Dyspepsia—Mometasone—systemic scleroderma	0.00536	0.00536	CcSEcCtD
Tolazamide—Ill-defined disorder—Azathioprine—systemic scleroderma	0.00531	0.00531	CcSEcCtD
Tolazamide—Fatigue—Mometasone—systemic scleroderma	0.00525	0.00525	CcSEcCtD
Tolazamide—Thrombocytopenia—Captopril—systemic scleroderma	0.00524	0.00524	CcSEcCtD
Tolazamide—Malaise—Azathioprine—systemic scleroderma	0.00516	0.00516	CcSEcCtD
Tolazamide—Leukopenia—Azathioprine—systemic scleroderma	0.00512	0.00512	CcSEcCtD
Tolazamide—Asthenia—Pentoxifylline—systemic scleroderma	0.00507	0.00507	CcSEcCtD
Tolazamide—Ill-defined disorder—Leflunomide—systemic scleroderma	0.00501	0.00501	CcSEcCtD
Tolazamide—Pruritus—Pentoxifylline—systemic scleroderma	0.005	0.005	CcSEcCtD
Tolazamide—Aplastic anaemia—Methotrexate—systemic scleroderma	0.00495	0.00495	CcSEcCtD
Tolazamide—Malaise—Leflunomide—systemic scleroderma	0.00487	0.00487	CcSEcCtD
Tolazamide—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.00486	0.00486	CcSEcCtD
Tolazamide—Vertigo—Leflunomide—systemic scleroderma	0.00485	0.00485	CcSEcCtD
Tolazamide—Leukopenia—Leflunomide—systemic scleroderma	0.00484	0.00484	CcSEcCtD
Tolazamide—Discomfort—Azathioprine—systemic scleroderma	0.00481	0.00481	CcSEcCtD
Tolazamide—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.00478	0.00478	CcSEcCtD
Tolazamide—Dyspepsia—Captopril—systemic scleroderma	0.00471	0.00471	CcSEcCtD
Tolazamide—Dizziness—Pentoxifylline—systemic scleroderma	0.00467	0.00467	CcSEcCtD
Tolazamide—Malaise—Mycophenolic acid—systemic scleroderma	0.00465	0.00465	CcSEcCtD
Tolazamide—Erythema—Lisinopril—systemic scleroderma	0.00464	0.00464	CcSEcCtD
Tolazamide—Vertigo—Mycophenolic acid—systemic scleroderma	0.00463	0.00463	CcSEcCtD
Tolazamide—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00461	0.00461	CcSEcCtD
Tolazamide—Fatigue—Captopril—systemic scleroderma	0.00461	0.00461	CcSEcCtD
Tolazamide—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00457	0.00457	CcSEcCtD
Tolazamide—Discomfort—Leflunomide—systemic scleroderma	0.00455	0.00455	CcSEcCtD
Tolazamide—Rash—Pentoxifylline—systemic scleroderma	0.00445	0.00445	CcSEcCtD
Tolazamide—Headache—Pentoxifylline—systemic scleroderma	0.00442	0.00442	CcSEcCtD
Tolazamide—Feeling abnormal—Captopril—systemic scleroderma	0.00441	0.00441	CcSEcCtD
Tolazamide—Asthenia—Mometasone—systemic scleroderma	0.00437	0.00437	CcSEcCtD
Tolazamide—Discomfort—Mycophenolic acid—systemic scleroderma	0.00434	0.00434	CcSEcCtD
Tolazamide—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00432	0.00432	CcSEcCtD
Tolazamide—Pruritus—Mometasone—systemic scleroderma	0.00431	0.00431	CcSEcCtD
Tolazamide—Ill-defined disorder—Lisinopril—systemic scleroderma	0.00431	0.00431	CcSEcCtD
Tolazamide—Nausea—Pentoxifylline—systemic scleroderma	0.00419	0.00419	CcSEcCtD
Tolazamide—Malaise—Lisinopril—systemic scleroderma	0.00419	0.00419	CcSEcCtD
Tolazamide—Vertigo—Lisinopril—systemic scleroderma	0.00417	0.00417	CcSEcCtD
Tolazamide—Leukopenia—Lisinopril—systemic scleroderma	0.00416	0.00416	CcSEcCtD
Tolazamide—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00412	0.00412	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00403	0.00403	CcSEcCtD
Tolazamide—Abdominal distension—Prednisone—systemic scleroderma	0.00398	0.00398	CcSEcCtD
Tolazamide—Discomfort—Lisinopril—systemic scleroderma	0.00391	0.00391	CcSEcCtD
Tolazamide—Dyspepsia—Leflunomide—systemic scleroderma	0.00388	0.00388	CcSEcCtD
Tolazamide—Feeling abnormal—Azathioprine—systemic scleroderma	0.00385	0.00385	CcSEcCtD
Tolazamide—Rash—Mometasone—systemic scleroderma	0.00384	0.00384	CcSEcCtD
Tolazamide—Asthenia—Captopril—systemic scleroderma	0.00384	0.00384	CcSEcCtD
Tolazamide—Headache—Mometasone—systemic scleroderma	0.00382	0.00382	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00381	0.00381	CcSEcCtD
Tolazamide—Fatigue—Leflunomide—systemic scleroderma	0.0038	0.0038	CcSEcCtD
Tolazamide—Pruritus—Captopril—systemic scleroderma	0.00379	0.00379	CcSEcCtD
Tolazamide—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00377	0.00377	CcSEcCtD
Tolazamide—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00371	0.00371	CcSEcCtD
Tolazamide—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.0037	0.0037	CcSEcCtD
Tolazamide—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00367	0.00367	CcSEcCtD
Tolazamide—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00365	0.00365	CcSEcCtD
Tolazamide—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00364	0.00364	CcSEcCtD
Tolazamide—Feeling abnormal—Leflunomide—systemic scleroderma	0.00363	0.00363	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00363	0.00363	CcSEcCtD
Tolazamide—Fatigue—Mycophenolic acid—systemic scleroderma	0.00363	0.00363	CcSEcCtD
Tolazamide—Nausea—Mometasone—systemic scleroderma	0.00362	0.00362	CcSEcCtD
Tolazamide—Dizziness—Captopril—systemic scleroderma	0.00354	0.00354	CcSEcCtD
Tolazamide—Urticaria—Leflunomide—systemic scleroderma	0.0035	0.0035	CcSEcCtD
Tolazamide—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00347	0.00347	CcSEcCtD
Tolazamide—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00342	0.00342	CcSEcCtD
Tolazamide—Rash—Captopril—systemic scleroderma	0.00337	0.00337	CcSEcCtD
Tolazamide—Headache—Captopril—systemic scleroderma	0.00335	0.00335	CcSEcCtD
Tolazamide—Dyspepsia—Lisinopril—systemic scleroderma	0.00334	0.00334	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00327	0.00327	CcSEcCtD
Tolazamide—Fatigue—Lisinopril—systemic scleroderma	0.00327	0.00327	CcSEcCtD
Tolazamide—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00325	0.00325	CcSEcCtD
Tolazamide—Nausea—Captopril—systemic scleroderma	0.00318	0.00318	CcSEcCtD
Tolazamide—Asthenia—Leflunomide—systemic scleroderma	0.00316	0.00316	CcSEcCtD
Tolazamide—Pancytopenia—Methotrexate—systemic scleroderma	0.00314	0.00314	CcSEcCtD
Tolazamide—Feeling abnormal—Lisinopril—systemic scleroderma	0.00312	0.00312	CcSEcCtD
Tolazamide—Pruritus—Leflunomide—systemic scleroderma	0.00312	0.00312	CcSEcCtD
Tolazamide—Dizziness—Azathioprine—systemic scleroderma	0.00309	0.00309	CcSEcCtD
Tolazamide—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Tolazamide—Asthenia—Mycophenolic acid—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Tolazamide—Urticaria—Lisinopril—systemic scleroderma	0.00301	0.00301	CcSEcCtD
Tolazamide—Pruritus—Mycophenolic acid—systemic scleroderma	0.00298	0.00298	CcSEcCtD
Tolazamide—Rash—Azathioprine—systemic scleroderma	0.00294	0.00294	CcSEcCtD
Tolazamide—Headache—Azathioprine—systemic scleroderma	0.00293	0.00293	CcSEcCtD
Tolazamide—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00292	0.00292	CcSEcCtD
Tolazamide—Dizziness—Leflunomide—systemic scleroderma	0.00292	0.00292	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00287	0.00287	CcSEcCtD
Tolazamide—Dizziness—Mycophenolic acid—systemic scleroderma	0.00278	0.00278	CcSEcCtD
Tolazamide—Rash—Leflunomide—systemic scleroderma	0.00278	0.00278	CcSEcCtD
Tolazamide—Nausea—Azathioprine—systemic scleroderma	0.00277	0.00277	CcSEcCtD
Tolazamide—Headache—Leflunomide—systemic scleroderma	0.00276	0.00276	CcSEcCtD
Tolazamide—Erythema—Prednisone—systemic scleroderma	0.00276	0.00276	CcSEcCtD
Tolazamide—Agranulocytosis—Methotrexate—systemic scleroderma	0.00275	0.00275	CcSEcCtD
Tolazamide—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00274	0.00274	CcSEcCtD
Tolazamide—Asthenia—Lisinopril—systemic scleroderma	0.00272	0.00272	CcSEcCtD
Tolazamide—Pruritus—Lisinopril—systemic scleroderma	0.00268	0.00268	CcSEcCtD
Tolazamide—Rash—Mycophenolic acid—systemic scleroderma	0.00265	0.00265	CcSEcCtD
Tolazamide—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00264	0.00264	CcSEcCtD
Tolazamide—Headache—Mycophenolic acid—systemic scleroderma	0.00264	0.00264	CcSEcCtD
Tolazamide—Nausea—Leflunomide—systemic scleroderma	0.00262	0.00262	CcSEcCtD
Tolazamide—Ill-defined disorder—Prednisone—systemic scleroderma	0.00256	0.00256	CcSEcCtD
Tolazamide—Dizziness—Lisinopril—systemic scleroderma	0.00251	0.00251	CcSEcCtD
Tolazamide—Nausea—Mycophenolic acid—systemic scleroderma	0.0025	0.0025	CcSEcCtD
Tolazamide—Malaise—Prednisone—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Tolazamide—Vertigo—Prednisone—systemic scleroderma	0.00248	0.00248	CcSEcCtD
Tolazamide—Rash—Lisinopril—systemic scleroderma	0.00239	0.00239	CcSEcCtD
Tolazamide—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Tolazamide—Headache—Lisinopril—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Tolazamide—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00235	0.00235	CcSEcCtD
Tolazamide—Discomfort—Prednisone—systemic scleroderma	0.00232	0.00232	CcSEcCtD
Tolazamide—Erythema—Methotrexate—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Tolazamide—Nausea—Lisinopril—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Tolazamide—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Tolazamide—Ill-defined disorder—Methotrexate—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Tolazamide—Rash—Mycophenolate mofetil—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Tolazamide—Headache—Mycophenolate mofetil—systemic scleroderma	0.00208	0.00208	CcSEcCtD
Tolazamide—Malaise—Methotrexate—systemic scleroderma	0.00208	0.00208	CcSEcCtD
Tolazamide—Vertigo—Methotrexate—systemic scleroderma	0.00207	0.00207	CcSEcCtD
Tolazamide—Leukopenia—Methotrexate—systemic scleroderma	0.00206	0.00206	CcSEcCtD
Tolazamide—Dyspepsia—Prednisone—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Tolazamide—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Tolazamide—Fatigue—Prednisone—systemic scleroderma	0.00194	0.00194	CcSEcCtD
Tolazamide—Discomfort—Methotrexate—systemic scleroderma	0.00194	0.00194	CcSEcCtD
Tolazamide—Feeling abnormal—Prednisone—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Tolazamide—Thrombocytopenia—Methotrexate—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Tolazamide—Urticaria—Prednisone—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Tolazamide—Dyspepsia—Methotrexate—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Tolazamide—Fatigue—Methotrexate—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Tolazamide—Asthenia—Prednisone—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Tolazamide—Pruritus—Prednisone—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Tolazamide—Feeling abnormal—Methotrexate—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Tolazamide—Urticaria—Methotrexate—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Tolazamide—Dizziness—Prednisone—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Tolazamide—Rash—Prednisone—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Tolazamide—Headache—Prednisone—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Tolazamide—Asthenia—Methotrexate—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Tolazamide—Nausea—Prednisone—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Tolazamide—Pruritus—Methotrexate—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Tolazamide—Dizziness—Methotrexate—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Tolazamide—Rash—Methotrexate—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Tolazamide—Headache—Methotrexate—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Tolazamide—Nausea—Methotrexate—systemic scleroderma	0.00112	0.00112	CcSEcCtD
